Medidata Earns Recognition as Leading Innovative Company and a Great Place to Work®
August 07 2017 - 8:30AM
Business Wire
Medidata is named by Forbes as one of the
world’s most innovative companies and listed as a Great Place to
Work by FORTUNE. Medidata is the only company in its space to
appear on either list
Medidata (NASDAQ: MDSO), the leading global provider of
cloud-based technology and data analytics for clinical research,
today announced that it has received recognition from two
prestigious business publications for its innovation and work
environment. Medidata is the only technology company within the
global life sciences sector to receive either award.
Forbes magazine named Medidata as one of The World's Most
Innovative Growth Companies for 2017, and is ranked 59th globally.
Additionally, the company has for the second consecutive year been
listed a Best Workplace in New York by FORTUNE, ranking 16th among
large companies in New York.
“Our ability to attract and retain an incredibly skilled,
diverse, motivated and empowered workforce goes hand-in-hand with
the impressive innovation we’re bringing to market,” said Glen de
Vries, Medidata president and co-founder. “Investment in the growth
and engagement of our employees is a core value for Medidata, and
we firmly believe that the return on investment is enormous. Thanks
to our strong team, we are able to deliver to our customers
innovative technology and solutions, which address real research
and business issues they face today, as well as those of the
future.”
An example of such technology is Medidata’s Synthetic Control
Arm (SCA), which reuses subject level data from multiple historic
clinical trials to create a well-matched, patient-level comparator
group without recruiting new control patients. SCA provides better
science and efficiency for clinical trials by creating a
data-based, low-bias, high-confidence comparator for interpreting
the uncontrolled treatment.
The Forbes’s list of Most Innovative Growth Companies for 2017
is based on investors’ ability to identify firms they expect to be
innovative now and in the future. To qualify, firms need seven
years of public financial data between $2-10 billion in market cap
and they need to belong to an industry that is known to invest in
innovation.
The Best Workplaces in New York is one of a series of rankings
by Great Place to Work and FORTUNE based on employee feedback from
Great Place to Work–Certified™ organizations. The list considered
137,000 employee surveys about culture, leadership, benefits and
other factors crucial to an outstanding employee experience.
About MedidataMedidata is reinventing global drug and
medical device development by creating the industry's leading
cloud-based solutions for clinical research. Through our advanced
applications and intelligent data analytics, Medidata helps advance
the scientific goals of life sciences customers worldwide,
including more than 850 global pharmaceutical companies, innovative
biotech, diagnostic and device firms, leading academic medical
centers, and contract research organizations.
The Medidata Clinical Cloud® brings a new level of quality and
efficiency to clinical trials that empower our customers to make
more informed decisions earlier and faster. Our unparalleled
clinical trial data assets provide deep insights that pave the way
for future growth. The Medidata Clinical Cloud is the primary
technology solution powering clinical trials for 18 of the world's
top 25 global pharmaceutical companies and is used by 18 of the top
25 medical device developers—from study design and planning through
execution, management and reporting.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170807005306/en/
Medidata SolutionsInvestor:Anthony D’Amico,
+1 732-767-4331adamico@mdsol.comorMedia:Erik Snider,
+1 646-362-2997esnider@mdsol.com
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Apr 2023 to Apr 2024